Knockdown of optineurin controls C2C12 myoblast differentiation via regulating myogenin and MyoD expressions
Knockdown of optineurin controls C2C12 myoblast differentiation via regulating myogenin and MyoD expressions
复制标题
DOI:
10.1016/j.diff.2021.11.004
复制
发表时间:
2021-11-26
期刊:
影响因子:
2.9
通讯作者:
Maruyama, Hirofumi
中科院分区:
文献类型:
--
作者:
Ishikawa, Kenichi;Araki, Mutsuko;Maruyama, Hirofumi
Mutations in optineurin (OPTN) have been identified in a small proportion of sporadic and familial amyotrophic lateral sclerosis (ALS) cases. Recent evidences suggest that OPTN would be involved in not only the patho-physiological mechanisms of motor neuron death of ALS but also myofiber degeneration of sporadic inclusion body myositis. However, the detailed role of OPTN in muscle remains unclear. Initially, we showed that OPTN expression levels were significantly increased in the denervated muscles of mice, suggesting that OPTN may be involved in muscle homeostasis. To reveal the molecular role of OPTN in muscle atrophy, we used cultured C2C12 myotubes treated with tumor necrosis factor-like inducer of apoptosis (TWEAK) as an in vitro model of muscle atrophy. Our data showed that OPTN had no effect on the process of muscle atrophy in this model. On the other hand, we found that myogenic differentiation was affected by OPTN. Immunoblotting analysis showed that OPTN protein levels gradually decreased during C2C12 differentiation. Furthermore, OPTN knockdown inhibited C2C12 differentiation, accompanied by reduction of mRNA and protein expression levels of myogenin and MyoD. These findings suggested that OPTN may have a novel function in muscle homeostasis and play a role in the pathogenesis of neuromuscular diseases.